Knott David M Jr Poseida Therapeutics, Inc. Transaction History

Knott David M Jr

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$3.08 - $8.73 $85,987 - $243,724	-27,918 Reduced 16.54%	140,921 $434,000
Q4 2022 Feb 13, 2023	BUY	$3.33 - $6.38 $58,451 - $111,988	17,553 Added 11.6%	168,839 $895,000
Q3 2022 Nov 10, 2022	BUY	$2.43 - $4.51 $367,624 - $682,299	151,286 New	151,286 $534,000
Q1 2022 May 16, 2022	SELL	$3.22 - $7.04 $63,002 - $137,744	-19,566 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$6.23 - $7.6 $121,896 - $148,701	19,566 New	19,566 $133,000

119

40.7M

135K

439K

Ticker PSTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 85,775,600
Market Cap $815M
Description
Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant ...

Get notified when there are updates to the investment portfolio of Knott David M Jr, based on Form 13F filings with the SEC.

Stay updated on Knott David M Jr with notifications on news.